Evidence map›Paper›PMID 28094031›Full record

Trial reportKidney international2017

Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.

Amit X Garg, Rita S Suri, Paul Eggers, Fredric O Finkelstein, Tom Greene, Paul L Kimmel, Alan S Kliger, Brett Larive, Robert M Lindsay, Andreas Pierratos and 3 more

Abstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Kidney international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Interventions for fatigue in people with kidney failure requiring dialysis.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Guideline
  3. Effect of hemodiafiltration on measured physical activity: primary results of the HDFIT randomized controlled trial.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Bringing the end-stage kidney disease life plan home.Current opinion in nephrology and hypertension · 2025
    Article
  10. Article
  11. Pay-for-performance programs effectiveness in healthcare: the case of the end-stage renal disease quality incentive program.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Article
  12. Article
  13. Fatigue in Patients Receiving Maintenance Hemodialysis: A Review.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2023
    Review
  14. Post-dialysis recovery time in ESRD patients receiving more frequent hemodialysis in skilled nursing facilities.Hemodialysis international. International Symposium on Home Hemodialysis · 2022
    Article
  15. Patient Preferences for Longer or More Frequent In-Center Hemodialysis Regimens: A Multicenter Discrete Choice Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2022
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Amit X GargDivision of Nephrology, Department of Medicine, Western University, London, Ontario, Canada. Electronic address: amit.garg@lhsc.on.ca.
Rita S SuriDepartment of Medicine, Section of Nephrology, Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Paul EggersNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Fredric O FinkelsteinYale School of Medicine and Yale New Haven Health System, New Haven, Connecticut, USA.
Tom GreeneUniversity of Utah Medical Center, Salt Lake City, Utah, USA.
Paul L KimmelDivision of Kidney Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Alan S KligerYale School of Medicine and Yale New Haven Health System, New Haven, Connecticut, USA.
Brett LariveDepartment of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Robert M LindsayDivision of Nephrology, Department of Medicine, Western University, London, Ontario, Canada.
Andreas PierratosHumber River Hospital, University of Toronto, Toronto, Canada.
Mark UnruhDepartment of Internal Medicine, Division of Nephrology, University of New Mexico, Albuquerque, New Mexico, USA.
Glenn M ChertowDepartment of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
Frequent Hemodialysis Network Trial Investigators

Funding

Frequent Hemodialysis Network - West Coast ConsortiumU01DK066481 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHERTOW, GLENN MATTHEW · 2003 to 2010
$5.2M
NIDDK NIH HHS U01 DK066481
6 · The paper itself

Abstract

Most patients with end-stage kidney disease value their health-related quality of life (HRQoL) and want to know how it will be affected by their dialysis modality. We extended the findings of two prior clinical trial reports to estimate the effects of frequent compared to conventional hemodialysis on additional measures of HRQoL. The Daily Trial randomly assigned 245 patients to receive frequent (six times per week) or conventional (three times per week) in-center hemodialysis. The Nocturnal Trial randomly assigned 87 patients to receive frequent nocturnal (six times per week) or conventional (three times per week) home hemodialysis. All patients were on conventional hemodialysis prior to randomization, with an average feeling thermometer score of 70 to 75 (a visual analog scale from 0 to 100 where 100 is perfect health), an average general health scale score of 40 to 47 (a score from 0 to 100 where 100 is perfect health), and an average dialysis session recovery time of 2 to 3 hours. Outcomes are reported as the between-treatment group differences in one-year change in HRQoL measures and analyzed using linear mixed effects models. After one year in the Daily Trial, patients assigned to frequent in-center hemodialysis reported a higher feeling thermometer score, better general health, and a shorter recovery time after a dialysis session compared to standard thrice-weekly dialysis. After one year in the Nocturnal Trial, patients assigned to frequent home hemodialysis also reported a shorter recovery time after a dialysis session, but no statistical difference in their feeling thermometer or general health scores compared to standard home dialysis schedules. Thus, patients receiving day or nocturnal hemodialysis on average recovered approximately one hour earlier from a frequent compared to conventional hemodialysis session. Patients treated in an in-center dialysis facility reported better HRQoL with frequent compared to conventional hemodialysis.

Indexed as

Quality of LifeAdultAgedCanadaFemaleHealth StatusHealth Status IndicatorsHumansKidney Failure, ChronicMaleMiddle AgedProspective StudiesRenal DialysisSurveys and QuestionnairesTime FactorsTreatment Outcomeclinical trialdaily hemodialysishealth-related quality of lifenocturnal hemodialysis

Identifiers

PMID28094031
PMCPMC5333984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.